LPL Financial’s DexCom DXCM Stock Holding History

LPL Financial’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-15,000	Closed	-$996K	–	6037
2025 Q4	$996K	Buy	15,000 +3,000	+25%	+$194K	﹤0.01%	4083
2025 Q3	$807K	Buy	+12,000	New	+$950K	﹤0.01%	4208

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

LPL Financial's DXCM Position: Q2 2026 in Review

LPL Financial reduced its DexCom (DXCM) stake by 5.7% in Q2 2026, selling an estimated $1.39M and leaving 344,539 shares worth $23.2M. The position accounts for 0.01% of the portfolio, ranked #1479.

LPL Financial first reported a position in DXCM in Q2 2015 and has held it in 42 quarters since. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

LPL Financial held 344,539 shares of DexCom worth $23.2M as of Q2 2026.
LPL Financial sold 20,826 DexCom shares in Q2 2026, an estimated $1.39M.
DexCom made up 0.01% of LPL Financial's portfolio in Q2 2026, its #1479 holding.
LPL Financial first reported a position in DexCom in Q2 2015 and has held it in 42 quarters since.
976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.